Terms: = Germ cell tumor AND HOXD13, SPD, 3239, P35453, HOX4I AND Prognosis
8 results:
1. Predicting the survival of patients with pancreatic neuroendocrine neoplasms using deep learning: A study based on Surveillance, Epidemiology, and End Results database.
Jiang C; Wang K; Yan L; Yao H; Shi H; Lin R
Cancer Med; 2023 Jun; 12(11):12413-12424. PubMed ID: 37165971
[TBL] [Abstract] [Full Text] [Related]
2. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
Zhong J; Xiang D; Ma X
Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
[TBL] [Abstract] [Full Text] [Related]
3. Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study.
Rossi E; Zizzari IG; Di Filippo A; Acampora A; Pagliara MM; Sammarco MG; Simmaco M; Lionetto L; Botticelli A; Bria E; Marchetti P; Blasi MA; Tortora G; Schinzari G; Nuti M
Hum Vaccin Immunother; 2022 May; 18(3):2034377. PubMed ID: 35258435
[TBL] [Abstract] [Full Text] [Related]
4. The Change of Soluble Programmed cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes.
Ding XC; Wang LL; Zhu YF; Li YD; Nie SL; Yang J; Liang H; Weichselbaum RR; Yu JM; Hu M
Front Immunol; 2020; 11():580335. PubMed ID: 33224142
[TBL] [Abstract] [Full Text] [Related]
5. CD24 and PRAME Are Novel Grading and Prognostic Indicators for Pineal Parenchymal tumors of Intermediate Differentiation.
Wu X; Wang W; Lai X; Zhou Y; Zhou X; Li J; Liang Y; Zhu X; Ren X; Ding Y; Liang L
Am J Surg Pathol; 2020 Jan; 44(1):11-20. PubMed ID: 31567202
[TBL] [Abstract] [Full Text] [Related]
6. Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.
Zhou J; Mahoney KM; Giobbie-Hurder A; Zhao F; Lee S; Liao X; Rodig S; Li J; Wu X; Butterfield LH; Piesche M; Manos MP; Eastman LM; Dranoff G; Freeman GJ; Hodi FS
Cancer Immunol Res; 2017 Jun; 5(6):480-492. PubMed ID: 28522460
[TBL] [Abstract] [Full Text] [Related]
7. DNA methylation profiles of long- and short-term glioblastoma survivors.
Shinawi T; Hill VK; Krex D; Schackert G; Gentle D; Morris MR; Wei W; Cruickshank G; Maher ER; Latif F
Epigenetics; 2013 Feb; 8(2):149-56. PubMed ID: 23291739
[TBL] [Abstract] [Full Text] [Related]
8. Findings of computed tomography in stage IIB and IIC melanoma: a six-year retrospective study in the South-East of Scotland.
Orfaniotis G; Mennie JC; Fairbairn N; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Sep; 65(9):1216-9. PubMed ID: 22525255
[TBL] [Abstract] [Full Text] [Related]
